Distribution Appropriateness Committee
In order to achieve transparency and efficiency in the distribution of pharmaceuticals, the committee works to resolve various issues through consultations with related organizations and the government, and makes policy proposals as the Pharmaceutical Manufacturers Association of Japan (PMAJ).
Announcements and Updates
-
Distribution Appropriateness Committee
The article by Mr. Kumagai, Chairperson of the Distribution Optimization Committee, was published in the "Nikkan Yakugyo" (Daily Pharmaceutical Daily News).
-
Distribution Appropriateness Committee
Voluntary Action Plan for Optimization of Distribution and Productivity Improvement" was published.
-
Distribution Appropriateness Committee
The "Industry Standard for the Use of Information on Commercial Pharmaceutical Transactions between Wholesalers and Manufacturers" (Version 3.5), to be revised as of October 1, 2023, is posted.
Contents of the Distribution Optimization Committee
-
Implementation Plan
The implementation plan for this fiscal year is posted.
-
Industry standards for the use of information on pharmaceutical commercial transactions between wholesalers and manufacturers
Since then, we have been summarizing and standardizing issues of the time and posting them on our website.
-
Voluntary Action Plan for Optimization of Distribution and Productivity Improvement
The Pharmaceutical Manufacturers Association of Japan (PMAJ), an organization of manufacturers and distributors, has formulated a "Voluntary Action Plan for Optimizing Distribution and Improving Productivity".
-
Information from the Committee for Optimization of Distribution
Various announcements from the Distribution Optimization Committee are posted on this website.